• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用羟丙基甲基纤维素和柠檬酸制备磷酸钙-硫酸钙可注射性骨替代物。

Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using hydroxy-propyl-methyl-cellulose and citric acid.

机构信息

Department of Biomedical Engineering and Materials, School of Medicine, Soonchunhyang University, 366-1 Ssangyoung-Dong, 330-090 Cheonan, Republic of Korea.

出版信息

J Mater Sci Mater Med. 2010 Jun;21(6):1867-74. doi: 10.1007/s10856-010-4058-9. Epub 2010 Mar 24.

DOI:10.1007/s10856-010-4058-9
PMID:20333539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2882049/
Abstract

In this study, an injectable bone substitute (IBS) consisting of citric acid, chitosan, and hydroxyl propyl methyl cellulose (HPMC) as the liquid phase and tetra calcium phosphate (TTCP), dicalcium phosphate dihydrate (DCPD) and calcium sulfate dehydrate (CSD, CaSO4 x 2H2O) powders as the solid phase, were fabricated. Two groups were classified based on the percent of citric acid in the liquid phase (20, 40 wt%). In each groups, the HPMC percentage was 0, 2, and 4 wt%. An increase in compressive strength due to changes in morphology was confirmed by scanning electron microscopy images. A good conversion rate of HAp at 20% citric acid was observed in the XRD profiles. In addition, HPMC was not obviously affected by apatite formation. However, both HPMC and citric acid increased the compressive strength of IBS. The maximum compressive strength for IBS was with 40% citric acid and 4% HPMC after 14 days of incubation in 100% humidity at 37 degrees C.

摘要

在这项研究中,制备了一种由柠檬酸、壳聚糖和羟丙基甲基纤维素(HPMC)作为液相,以及磷酸四钙(TTCP)、二水磷酸二钙(DCPD)和硫酸钙脱水(CSD,CaSO4 x 2H2O)粉末作为固相组成的可注射骨替代物(IBS)。根据液相中柠檬酸的百分比(20、40wt%)将两组进行分类。在每组中,HPMC 的百分比分别为 0、2 和 4wt%。通过扫描电子显微镜图像证实,由于形态变化,抗压强度增加。在 XRD 图谱中观察到 20%柠檬酸时 HAp 的转化率很好。此外,HPMC 对磷灰石的形成没有明显影响。然而,HPMC 和柠檬酸都增加了 IBS 的抗压强度。在 37 摄氏度 100%湿度下孵育 14 天后,含有 40%柠檬酸和 4%HPMC 的 IBS 的抗压强度达到最大值。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/a928ae208c37/10856_2010_4058_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/cd082d32a38f/10856_2010_4058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/804200ed7248/10856_2010_4058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/88ce5c312d32/10856_2010_4058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/da0596e02c2e/10856_2010_4058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/11c0e7f88f7a/10856_2010_4058_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/2cee223021c3/10856_2010_4058_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/a928ae208c37/10856_2010_4058_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/cd082d32a38f/10856_2010_4058_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/804200ed7248/10856_2010_4058_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/88ce5c312d32/10856_2010_4058_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/da0596e02c2e/10856_2010_4058_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/11c0e7f88f7a/10856_2010_4058_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/2cee223021c3/10856_2010_4058_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba76/2882049/a928ae208c37/10856_2010_4058_Fig7_HTML.jpg

相似文献

1
Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using hydroxy-propyl-methyl-cellulose and citric acid.使用羟丙基甲基纤维素和柠檬酸制备磷酸钙-硫酸钙可注射性骨替代物。
J Mater Sci Mater Med. 2010 Jun;21(6):1867-74. doi: 10.1007/s10856-010-4058-9. Epub 2010 Mar 24.
2
Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using chitosan and citric acid.使用壳聚糖和柠檬酸制备磷酸钙-硫酸钙可注射骨替代物
J Mater Sci Mater Med. 2009 Apr;20(4):935-41. doi: 10.1007/s10856-008-3642-8. Epub 2008 Dec 4.
3
Novel injectable calcium phosphate/chitosan composites for bone substitute materials.用于骨替代材料的新型可注射磷酸钙/壳聚糖复合材料
Acta Biomater. 2006 Sep;2(5):557-65. doi: 10.1016/j.actbio.2006.03.007. Epub 2006 Jun 13.
4
Bioactive glass incorporation in calcium phosphate cement-based injectable bone substitute for improved in vitro biocompatibility and in vivo bone regeneration.将生物活性玻璃掺入磷酸钙钙基可注射骨替代物中,以提高体外生物相容性和体内骨再生。
J Biomater Appl. 2014 Jan;28(5):739-56. doi: 10.1177/0885328213478256. Epub 2013 Mar 6.
5
The influence of the acidic component of the gas-foaming porogen used in preparing an injectable porous calcium phosphate cement on its properties: acetic acid versus citric acid.用于制备可注射多孔磷酸钙骨水泥的气体发泡致孔剂的酸性成分对其性能的影响:乙酸与柠檬酸的比较。
J Biomed Mater Res B Appl Biomater. 2008 Jul;86(1):208-16. doi: 10.1002/jbm.b.31008.
6
Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials.使用壳聚糖和柠檬酸开发用于骨替代材料的磷酸钙骨水泥。
Biomaterials. 2002 Feb;23(4):1091-101. doi: 10.1016/s0142-9612(01)00221-6.
7
Is there a chemical interaction between calcium phosphates and hydroxypropylmethylcellulose (HPMC) in organic/inorganic composites?磷酸钙与羟丙基甲基纤维素(HPMC)在有机/无机复合材料中是否存在化学相互作用?
J Biomed Mater Res. 2001 Feb;54(2):247-55. doi: 10.1002/1097-4636(200102)54:2<247::aid-jbm12>3.0.co;2-g.
8
Modulation of porosity in apatitic cements by the use of alpha-tricalcium phosphate-calcium sulphate dihydrate mixtures.通过使用α-磷酸三钙-二水硫酸钙混合物调节磷灰石水泥的孔隙率。
Biomaterials. 2005 Jun;26(17):3395-404. doi: 10.1016/j.biomaterials.2004.09.023.
9
A novel injectable, cohesive and toughened Si-HPMC (silanized-hydroxypropyl methylcellulose) composite calcium phosphate cement for bone substitution.一种新型可注射、黏合且增韧的 Si-HPMC(硅烷化羟丙基甲基纤维素)复合磷酸钙骨替代水泥。
Acta Biomater. 2014 Jul;10(7):3335-45. doi: 10.1016/j.actbio.2014.03.009. Epub 2014 Mar 20.
10
Comparative study on physicochemical properties of alpha-TCP / calcium sulphate dihydrate biomicroconcretes containing chitosan, sodium alginate or methylcellulose.α-TCP/二水硫酸钙生物微晶水泥中壳聚糖、海藻酸钠或甲基纤维素的理化性能比较研究。
Acta Bioeng Biomech. 2020;22(1):47-56.

引用本文的文献

1
Two decades of continuous progresses and breakthroughs in the field of bioactive ceramics and glasses driven by CICECO-hub scientists.在CICECO中心科学家的推动下,生物活性陶瓷与玻璃领域持续取得了二十年的进展与突破。
Bioact Mater. 2024 Jun 8;40:104-147. doi: 10.1016/j.bioactmat.2024.05.041. eCollection 2024 Oct.
2
XGB Modeling Reveals Improvement of Compressive Strength of Cement-Based Composites with Addition of HPMC and Chitosan.XGB建模揭示了添加羟丙基甲基纤维素(HPMC)和壳聚糖后水泥基复合材料抗压强度的提高。
Materials (Basel). 2024 Jan 11;17(2):374. doi: 10.3390/ma17020374.
3
Synthetic Calcium-Phosphate Materials for Bone Grafting.

本文引用的文献

1
Fabrication of calcium phosphate-calcium sulfate injectable bone substitute using chitosan and citric acid.使用壳聚糖和柠檬酸制备磷酸钙-硫酸钙可注射骨替代物
J Mater Sci Mater Med. 2009 Apr;20(4):935-41. doi: 10.1007/s10856-008-3642-8. Epub 2008 Dec 4.
2
Effect of the calcium to phosphate ratio of tetracalcium phosphate on the properties of calcium phosphate bone cement.磷酸四钙钙磷比对磷酸钙骨水泥性能的影响。
J Biomed Mater Res A. 2008 Jun 1;85(3):674-83. doi: 10.1002/jbm.a.31478.
3
Novel injectable calcium phosphate/chitosan composites for bone substitute materials.
用于骨移植的合成磷酸钙材料
Polymers (Basel). 2023 Sep 19;15(18):3822. doi: 10.3390/polym15183822.
4
Development of Injectable Calcium Sulfate and Self-Setting Calcium Phosphate Composite Bone Graft Materials for Minimally Invasive Surgery.可注射硫酸钙与自固化磷酸钙复合骨移植材料的微创外科手术应用开发。
Int J Mol Sci. 2022 Jul 8;23(14):7590. doi: 10.3390/ijms23147590.
5
3D Printing of Calcium Phosphate/Calcium Sulfate with Alginate/Cellulose-Based Scaffolds for Bone Regeneration: Multilayer Fabrication and Characterization.用于骨再生的藻酸盐/纤维素基支架磷酸钙/硫酸钙的3D打印:多层制造与表征
J Funct Biomater. 2022 Apr 25;13(2):47. doi: 10.3390/jfb13020047.
6
Injectable bone cements: What benefits the combination of calcium phosphates and bioactive glasses could bring?可注射骨水泥:磷酸钙与生物活性玻璃的组合能带来哪些益处?
Bioact Mater. 2022 Apr 20;19:217-236. doi: 10.1016/j.bioactmat.2022.04.007. eCollection 2023 Jan.
7
Formulation and Characterization of a New Injectable Bone Substitute Composed PVA/Borax/CaCO and Demineralized Bone Matrix.一种由聚乙烯醇/硼砂/碳酸钙和脱矿骨基质组成的新型可注射骨替代物的配方与表征
J Funct Biomater. 2021 Aug 11;12(3):46. doi: 10.3390/jfb12030046.
8
Synthesis and Characterization of Nanohydroxyapatite-Gelatin Composite with Streptomycin as Antituberculosis Injectable Bone Substitute.以链霉素为抗结核剂的纳米羟基磷灰石-明胶复合材料的合成与表征,用于可注射骨替代物
Int J Biomater. 2019 Jun 25;2019:7179243. doi: 10.1155/2019/7179243. eCollection 2019.
9
Rheological and Mechanical Properties of Thermoresponsive Methylcellulose/Calcium Phosphate-Based Injectable Bone Substitutes.基于热响应性甲基纤维素/磷酸钙的可注射骨替代物的流变学和力学性能
Materials (Basel). 2018 Apr 14;11(4):604. doi: 10.3390/ma11040604.
10
Calcium Orthophosphate-Containing Biocomposites and Hybrid Biomaterials for Biomedical Applications.用于生物医学应用的含磷酸钙生物复合材料和混合生物材料。
J Funct Biomater. 2015 Aug 7;6(3):708-832. doi: 10.3390/jfb6030708.
用于骨替代材料的新型可注射磷酸钙/壳聚糖复合材料
Acta Biomater. 2006 Sep;2(5):557-65. doi: 10.1016/j.actbio.2006.03.007. Epub 2006 Jun 13.
4
Evaluation of an injectable bone substitute (betaTCP/hydroxyapatite/hydroxy-propyl-methyl-cellulose) in severely osteopenic and aged rats.注射用骨替代物(β-磷酸三钙/羟基磷灰石/羟丙基甲基纤维素)在重度骨质减少老龄大鼠中的评估
J Biomed Mater Res A. 2006 Sep 1;78(3):570-80. doi: 10.1002/jbm.a.30721.
5
New hydraulic cements based on alpha-tricalcium phosphate-calcium sulfate dihydrate mixtures.基于α-磷酸三钙-二水硫酸钙混合物的新型水硬性水泥。
Biomaterials. 2004 Feb;25(4):741-9. doi: 10.1016/s0142-9612(03)00573-8.
6
Kinetic study of citric acid influence on calcium phosphate bone cements as water-reducing agent.柠檬酸作为减水剂对磷酸钙骨水泥影响的动力学研究
J Biomed Mater Res. 2002 Sep 15;61(4):653-9. doi: 10.1002/jbm.10264.
7
Development of calcium phosphate cement using chitosan and citric acid for bone substitute materials.使用壳聚糖和柠檬酸开发用于骨替代材料的磷酸钙骨水泥。
Biomaterials. 2002 Feb;23(4):1091-101. doi: 10.1016/s0142-9612(01)00221-6.
8
Synthesis and characterization of macroporous chitosan/calcium phosphate composite scaffolds for tissue engineering.用于组织工程的大孔壳聚糖/磷酸钙复合支架的合成与表征
J Biomed Mater Res. 2001 Jun 5;55(3):304-12. doi: 10.1002/1097-4636(20010605)55:3<304::aid-jbm1018>3.0.co;2-j.
9
Is there a chemical interaction between calcium phosphates and hydroxypropylmethylcellulose (HPMC) in organic/inorganic composites?磷酸钙与羟丙基甲基纤维素(HPMC)在有机/无机复合材料中是否存在化学相互作用?
J Biomed Mater Res. 2001 Feb;54(2):247-55. doi: 10.1002/1097-4636(200102)54:2<247::aid-jbm12>3.0.co;2-g.
10
Conversion of octacalcium phosphate in calcium phosphate cements.磷酸钙骨水泥中磷酸八钙的转化
J Biomed Mater Res. 2000 Oct;52(1):95-106. doi: 10.1002/1097-4636(200010)52:1<95::aid-jbm12>3.0.co;2-x.